Carlow, Ireland
Merck Sharp and Dohme will begin construction in summer of 2009 on a €220 million vaccine manufacturing plant in Carlow, Ireland. Located in the IDA Business and Technology Park, the project includes formulation, manufacturing, and sterile filling facilities. Accommodating R&D, quality control, and administration, the building will support 170 employees and is expected to reach completion in 2011. Merck Sharp and Dohme is the U.K. subsidiary of Merck & Co.
